Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

iCo Therapeutics Inc V.ICO

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ICOTF

ICO Therapeutics Inc is a biotechnology company focused on the identification, development & commercialization of drug candidates with a clinical history & re-doses, reformulates & develops these drug candidates to treat sight & life-threatening diseases.
Price: $0.07 | Change: +$0.005 | %Change: +7.69%
Volume: 282,700 | Day High/Low: 0.075/0.065 | 52 Week High/Low: 0.37/0.025
View modes: 
0 stars

RE: We should see a breakout next week

You need to send your crystal ball for servicing. ICO is breaking out now!  rate and reply
0 stars

Anyone watch Letterman last night

Stayed up  just to watch it  rate and reply
2 stars

We should see a breakout next week

Should be a few more dollars in the bank  rate and reply
0 stars

RE:RE:32 million anyone remember the date?

thank you for that couldn't find it anywhere. We are under at year from  pay day 6 weeks shoudl bring news and a sp boost but with royalties could we get a divdiend for stick this out, iCo?  rate and reply
3 stars

Get ready

MZI is about to liftoff. A few big whales are getting involved. This will be the biggest play of 2015 going forward.  rate and reply
5 stars

RE:32 million anyone remember the date?

According to their AIF dated Apr 27th 2015 "if IMMUNE successfully develops and commercializes iCo-008 for systemic uses, iCo may receive up to an additional US$32 million in milestone payments as...read more
5 stars

32 million anyone remember the date?

Because this phase is 6 weeks only i would assume soon. Ninety patients are expected to be enrolled into the study, sixty of whom will be treated with Bertilimumab 7mg/kg and thirty of whom will be...read more
5 stars

$6 target on IMNP

http://www.dakotafinancialnews.com/chardan-capital-boosts-immune-pharmaceuticals-price-target-to-6-00-imnp/172700/  rate and reply
0 stars

Bertilimumab Phase II Trials Ready to Enroll Patients

Nice reading this getting closer NEW YORK, May 18, 2015 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP) ("Immune") announced financial results for the first quarter ended March 31, 2015....read more
0 stars

We are crawling towards the AGM

We are back in this i see someoen is accumulating they got tired or waiting and bought over 30 lots Time   Price Shares Change Exch/Mkt...read more
0 stars

RE:.08 by the end of d week?

more likely!  rate and reply
0 stars

.08 by the end of d week?

or more...?  rate and reply
5 stars

RE:RE:RE:RE:It's starting to move again

one day home run  rate and reply
5 stars

RE:RE:RE:It's starting to move again

give us 100% like to see it at .14 soon  rate and reply
5 stars

RE:RE:It's starting to move again

i have both YFI and ico plus an amount of XAU. XAU I have to watch each day it rises so fast but it is an ipo. YFI was my dream I have my first TSX 10 bagger there. This will blopw up and it will grow...read more
5 stars

RE:RE:It's starting to move again

Q1, Financials were a little south, (But there not broke) Currently on commencing phase 2, CEO of Immune commented, received strong interest In negotiation stage for a partnering agreement for phase 3...read more
3 stars

RE:It's starting to move again

asks are at 0.75.  This one is the next YFI. I have positions in both.  2015 has been definitely prosperous!  rate and reply
5 stars

It's starting to move again

http://www.stockhouse.com/news/press-releases/2015/05/19/life-sciences-and-biotechnology-leader-douglas-janzen-named-senior-clinical  rate and reply
0 stars

Not liking the charts on this

I still believe in this long term but I may have to move a portion out to cash so i can take a bit of profita nd reduce my exposure now as think this stock waits on IMNP co Therapeutics Inc...read more
0 stars

chart shouts out .04

Just so the mugs on this board know where I got my opinion on previous post. Absolutely no momo. here.  rate and reply